SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis

MLA

Smeester, Branden A., et al. “SEMA4C Is a Novel Target to Limit Osteosarcoma Growth, Progression, and Metastasis.” Oncogene, vol. 39, no. 5, Jan. 2020, pp. 1049–62. EBSCOhost, https://doi.org/10.1038/s41388-019-1041-x.

APA

Smeester, B. A., Slipek, N. J., Pomeroy, E. J., Bomberger, H. E., Shamsan, G. A., Peterson, J. J., Crosby, M. R., Draper, G. M., Becklin, K. L., Rahrmann, E. P., McCarthy, J. B., Odde, D. J., Wood, D. K., Largaespada, D. A., & Moriarity, B. S. (2020). SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis. Oncogene, 39(5), 1049–1062. https://doi.org/10.1038/s41388-019-1041-x

Chicago

Smeester, Branden A., Nicholas J. Slipek, Emily J. Pomeroy, Heather E. Bomberger, Ghaidan A. Shamsan, Joseph J. Peterson, Margaret R. Crosby, et al. 2020. “SEMA4C Is a Novel Target to Limit Osteosarcoma Growth, Progression, and Metastasis.” Oncogene 39 (5): 1049–62. doi:10.1038/s41388-019-1041-x.